Brainomix® Stroke Imaging Solution Improves Consistency of Image Interpretation for Doctors

OXFORD, England, June 21, 2019 /PRNewswire/ — e-CTA®, developed by Brainomix, provides fast, consistent collateral assessments powered by AI and Deep Learning, based on CTA analysis. The recently published CATS study showed that e-CTA® provides a real-time and fully automated approach to collateral scoring, with the potential to improve consistency of image interpretation.

The study demonstrated the high sensitivity and specificity of e-CTA®, independent of clinician input. This is very important especially when selecting ischemic stroke patients presenting symptoms beyond 6 hours or with an uncertain time of onset, as reflected in the recent European Stroke Organisation guidelines for mechanical thrombectomy. Expert neuroradiology input is rarely available in real-time at most hospitals around the world, especially at primary stroke centres from which patients need to be transferred to a comprehensive centre. Even when specialist neuroradiology opinion is readily available, e-CTA® offers the opportunity to improve inter-rater reliability, therefore helping select the right patients that can benefit the most from mechanical thrombectomy.

Dr George Harston, Brainomix Chief Medical and Innovation Officer & Consultant Stroke Physician, Oxford University Hospitals NHSFT stated: “The importance of good collateral blood flow for patient outcome in acute stroke treatment is well recognised. However, even expert collateral scores commonly suffer from inter-rater error. In this exciting study Brainomix has shown once again the value of AI to augment human performance. In this study, e-CTA improved consistency between neuroradiologists when used as a decision support tool. Even when used as a standalone tool e-CTA produced similar scores compared to experts, opening up the opportunity for reliable collateral assessment for all patients regardless of which hospital they attend.”

Read the full study here.

View original content to download multimedia:http://www.prnewswire.com/news-releases/brainomix-stroke-imaging-solution-improves-consistency-of-image-interpretation-for-doctors-300872748.html

SOURCE Brainomix

Staff

Recent Posts

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

16 hours ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

16 hours ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

16 hours ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

16 hours ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

16 hours ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…

16 hours ago